Fig. 1From: MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsAge-related penetrance of the main MEN1 manifestations. a Age-related penetrance of duodenopancreatic neuroendocrine tumors. b Age-related penetrance of pituitary tumors. c Age-related penetrance of primary hyperparathyroidismBack to article page